HAWRYLUK P. KENT (President & CEO) received a stock award from MBX BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001193125-26-035582
DirectorOfficer· President & CEO
Since Feb 2026
+199.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
199.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35.25K
Price / share
—
Trade value
—
% of position
5.3%
2/2/2026
664.26K→699.51K
Total
Net shares
+35.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +35.25K | — | — | 5.3% | 664.26K | 699.51K |
| Total | +35.25K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
164.50K shares
Shares
+164.50K
Strike price
39.07
Held after
164.50K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock164.50K shares | 2/2/2026 | A · Award | +164.50K | 39.07 | — | 164.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned468.28K
Total
468.28K indirect468.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 468.28K | Indirect |
| Total | 468.28K | 468.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported